Drug Profile
HX 01
Alternative Names: HX01Latest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Humanyx
- Class Antibodies
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 31 Aug 2023 Discontinued - Preclinical for Solid tumours (Metastatic disease) in Singapore (unspecified route)
- 28 May 2020 No recent reports of development identified for preclinical development in Solid-tumours(Metastatic disease) in Singapore
- 15 Apr 2016 Preclinical trials in Solid tumours in Singapore (unspecified route) before April 2016